• 
• 
• 
• 
• 

FDA News and Drug Updates

Cancer Drug Approvals: A Tale of 2 Views

Rucaparib Approved with a Companion Diagnostic Test for Patients with Advanced Ovarian Cancer

FDA Approves Rucaparib and Companion Diagnostic for Patients with Advanced Ovarian Cancer

Daratumumab Combination Approved for Multiple Myeloma

Supportive Care

A Taxing Consequence: Taxane Acute Pain Syndrome

Mark L. Zangardi, PharmD, BCOP

Helping Adolescents and Young Adults Confront Mortality

Meg Barbor, MPH

The Emerging Conversation About Physician-Assisted Death

Meg Barbor, MPH

View All Supportive Care Articles

Breast Cancer

ESR1 Mutations Occur Often in Estrogen Receptor–Positive Breast Cancer

Fulvestrant Is Shown to Be Superior to Anastrozole for Many Patients with Breast Cancer

MONARCH Studies of Abemaciclib Meet Progression-Free Survival End Point

View All Breast Cancer Articles

Conference Correspondent

New NCCN Distress Guidelines and Tools Encourage Patients to Speak Up

A Look at SIRT Y-90 and the SARAH Trial

Nursing Implications of Chimeric Antigen Receptor T-Cell Therapy

View All Conference Correspondent Articles

Most Popular Articles

Highlights from Best Practices in Lung Cancer Navigation Summit

TON - Supplements - Lung Cancer

Florida Pharmacy Students’ Perspectives on Careers in Oncology

Paige May, PharmD, BCOP, Joseph Ladd, PharmD

JHOP - June 2017 Vol 7, No 2 - Online First, Original Research

Welcome to the Second Annual Oncology Pharmacy Guide to New FDA Approvals

2017 Oncology Pharmacy Guide to New FDA Approvals

Moffitt Cancer Center: A Team Approach to Advancing Patient Care

TON - May 2017, Vol 10, No 3 - Cancer Center Profile